Cyclin-dependent protein kinase inhibitors in breast cancer treatment
Pierre Frères(Centre Hospitalier Universitaire de Liège), Guy Jérusalem(Centre Hospitalier Universitaire de Liège), Laurence Lousberg(Centre Hospitalier Chrétien)
Open Repository and Bibliography (University of Liège)
July 1, 2016
Cited by 0
Related Papers
Triple-negative breast cancer: treatment challenges and solutions
|Breast Cancer Targets and Therapy|2016|382
Cardio-Oncology Services: rationale, organization, and implementation
|European Heart Journal|2018|303
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
|The Lancet Oncology|2019|193
Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis
|JNCI Journal of the National Cancer Institute|2020|102